CAMBRIDGE, Mass., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the Jefferies Global Healthcare Conference in London, England. Mark Fitzpatrick, CFO of Aegerion, is scheduled to present on Thursday, November 15, 2012 at 1:40 pm GMT.
